Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
Total Current Assets
Beijing Hotgen Biotech Co Ltd
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Total Current Assets
¥828.2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Total Current Assets
¥30.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Total Current Assets
¥10.9B
|
CAGR 3-Years
29%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Total Current Assets
¥21.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Total Current Assets
¥11.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
47%
|
CAGR 10-Years
31%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Total Current Assets
¥8.7B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Total Current Assets?
Total Current Assets
828.2m
CNY
Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Total Current Assets amounts to 828.2m CNY.
What is Beijing Hotgen Biotech Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
45%
Over the last year, the Total Current Assets growth was -54%. The average annual Total Current Assets growth rates for Beijing Hotgen Biotech Co Ltd have been 12% over the past three years , 45% over the past five years .